NCT04902040 2026-03-18
Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies
M.D. Anderson Cancer Center
Phase 1/2 Terminated
M.D. Anderson Cancer Center
Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Mayo Clinic
Radiation Therapy Oncology Group